For patients with chronic kidney disease (CKD), the risk for emergently treated hypocalcemia with denosumab increases with ...

Denosumab treatment for osteoporosis appears more hazardous in postmenopausal women with advanced chronic kidney disease (CKD).

“She said she was approaching forty. I couldn’t help wondering from what direction.” ...

The geriatric population, with chronic kidney diseases, liver diseases, and metabolic disorders ... From November 18, 2024, through February 15, 2025, this initiative offers an exclusive discount for ...

Q3 2024 Earnings Call Transcript November 18, 2024 Operator: Good afternoon, ladies and gentlemen, and welcome to the NRx ...

The Expert Patients Programme (EPP) is a six-week course for anyone living with one or more long term health conditions such as asthma, chronic fatigue, COPD, depression, diabetes, heart disease, MS, ...

Good afternoon, ladies and gentlemen, and welcome to the NRx Pharmaceuticals third-quarter 2024 earnings conference call. (Operator Instructions) This call is being recorded on Monday, November 18, ...